Guided Therapeutics
(OTC) GTHP
Guided Therapeutics Financials at a Glance
Market Cap
$21.00M
Revenue (TTM)
$767.00K
Net Income (TTM)
$3.35M
EPS (TTM)
$-0.04
P/E Ratio
-5.23
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$0.22
Volume
15,680
Open
$0.24
Price
$0.22
Volume
15,680
Open
$0.24
Previous Close
$0.22
Daily Range
$0.20 - $0.24
52-Week Range
$0.07 - $0.54
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$0.22
Volume
15,680
Open
$0.24
Previous Close
$0.22
Daily Range
$0.20 - $0.24
52-Week Range
$0.07 - $0.54
GTHP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Guided Therapeutics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
8
CEO
Mark L. Faupel, PhD
Website
www.guidedinc.comHeadquarters
Norcross, GA 30092, US
GTHP Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
-3%
Net Income Margin
-4%
Return on Equity
0%
Return on Capital
45%
Return on Assets
-3%
Earnings Yield
-19.12%
Dividend Yield
0.00%
Payout Ratio
-3.41%
Stock Overview
Market Cap
$21.00M
Shares Outstanding
96.35M
Volume
15.68K
Short Interest
0.00%
Avg. Volume
17.00K
Financials (TTM)
Gross Profit
$571.00K
Operating Income
$2.37M
EBITDA
$2.47M
Operating Cash Flow
$1.07M
Capital Expenditure
$2.00K
Free Cash Flow
$1.07M
Cash & ST Invst.
$63.00K
Total Debt
$2.94M
Guided Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$590.00K
+58900.0%
Gross Profit
$458.00K
+23000.0%
Gross Margin
77.63%
N/A
Market Cap
$21.00M
N/A
Market Cap/Employee
$5.25M
N/A
Employees
4
N/A
Net Income
$1.37M
-109.5%
EBITDA
$1.01M
-103.6%
Quarterly Fundamentals
Net Cash
$2.88M
-62.4%
Accounts Receivable
$4.00K
+33.3%
Inventory
$448.00K
-29.2%
Long Term Debt
$694.00K
+519.6%
Short Term Debt
$2.25M
+9.7%
Return on Assets
-2.53%
N/A
Return on Invested Capital
44.65%
N/A
Free Cash Flow
$291.00K
+12.3%
Operating Cash Flow
$291.00K
+12.3%